Thierry Dujardin

Turcotte B, Bélanger L, Blais AS, Blouin AC, Bolduc S, Bolduc-Mokhtar A, Bureau M, Caumartin Y, Cloutier J, Deschênes-Rompré MP, Dujardin T, Fradet Y, Gaudreau N, Lacombe L, Moore K, Morin F, Nadeau G, Paquet S, Simard F, Simonyan D, Soucy F, Tiguert R, Toren P, Lodde M, Pouliot F

Perception and satisfaction of patients after telemedicine urology consultations: A matched analysis with physicians' perspective

Can Urol Assoc J, 16 (10), 2022.

Résumé | Liens:

Fradet S, Pelletier JF, Singbo N, Lacombe L, Toren P, Lodde M, Dujardin T, Tiguert R, Fradet Y, Robitaille K, Fradet V

Effects of omega-3 fatty acids supplementation on perioperative blood loss and complications after radical prostatectomy

Clin Nutr ESPEN, 47 , 2022.

Résumé | Liens:

Pavlovich CP, Hyndman ME, Eure G, Ghai S, Caumartin Y, Herget E, Young JD, Wiseman D, Caughlin C, Gray R, Wason S, Mettee L, Lodde M, Toi A, Dujardin T, Lance R, Schatz SM, Fabrizio M, Malcolm JB, Fradet V

A multi-institutional randomized controlled trial comparing first-generation transrectal high-resolution micro-ultrasound with conventional frequency transrectal ultrasound for prostate biopsy

BJUI Compass, 2 (2), 2021.

Résumé | Liens:

Otis-Chapados S, Goulet CR, Dubois G, Lavallée É, Dujardin T, Fradet Y, Lacombe L, Lodde M, Tiguert R, Toren P, Fradet V, Beauregard JM, Buteau FA, Pouliot F

18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphy

Can Urol Assoc J, 15 (10), 2021.

Résumé | Liens:

Turcotte B, Paquet S, Blais AS, Blouin AC, Bolduc S, Bureau M, Caumartin Y, Cloutier J, Deschênes-Rompré MP, Dujardin T, Fradet Y, Lacombe L, Moore K, Morin F, Nadeau G, Simonyan D, Soucy F, Tiguert R, Toren P, Lodde M, Pouliot F

A prospective, multisite study analyzing the percentage of urological cases that can be completely managed by telemedicine

Can Urol Assoc J, 14 (10), 2020.

Résumé | Liens:

Lavallée E, Bergeron M, Buteau FA, Blouin AC, Duchesnay N, Dujardin T, Tiguert R, Lacombe L, Fradet V, Makao-Nguile M, Fradet Y, Beauregard JM, Pouliot F

Increased Prostate Cancer Glucose Metabolism Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Localised Gleason 8-10 Prostate Cancers Identifies Very High-risk Patients for Early Recurrence and Resistance to Castration

Eur Urol Focus, 5 (6), 2019.

Résumé | Liens:

Fradet V, Toren P, Nguile-Makao M, Lodde M, Levesque J, Leger C, Caron A, Bergeron A, Ben-Zvi T, Lacombe L, Pouliot F, Tiguert R, Dujardin T, Fradet Y

Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors

BJU Int, 121 (3), 2018.

Résumé | Liens:

Beauregard JM, Blouin AC, Fradet V, Caron A, Fradet Y, Lemay C, Lacombe L, Dujardin T, Tiguert R, Rimac G, Bouchard F, Pouliot F

FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy

Cancer Imaging, 15 , 2015.

Résumé | Liens:

Bessede T, Bigot P, Bernhard JC, Pignot G, Bouliere F, Verhoest G, Crepel M, Salomon L, Mottet N, Bellec L, Soulie M, Ferriere JM, Pfister C, Albouy B, Pouliot F, Dujardin T, Bensalah K, Patard JJ

Are warm ischemia and ischemia time still predictive factors of poor renal function after partial nephrectomy in the setting of elective indication?

World J Urol, 33 (1), 2015.

Résumé | Liens:

Alesawi A, Nadeau G, Bergeron A, Dujardin T, Lacombe L, Caumartin Y

Cystatin C for early detection of acute kidney injury after laparoscopic partial nephrectomy

Urol Ann, 6 (4), 2014.

Résumé | Liens: